FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898494504> ?p ?o ?g. }

• W2898494504 abstract "Background: There is limited research detailing LDL trends over the long term in children on various lipid lowering medications. Objectives: This study sought to assess factors associated with stability of LDL levels in children on long-term pharmacotherapy and their ability to reach the current recommended LDL goal of 130 mg/dL or less while on pharmacotherapy. Methods: Medical records of children seen in a university pediatric cholesterol clinic between 1998 and 2012 who were treated with a statin, ezetimibe, or both were reviewed. Aggregate data were obtained to determine the number of children who were able to reach an LDL level of 130 mg/dL or less while on pharmacotherapy. Kaplan-Meier curve and proportional hazard regression analysis were used to examine the propensity for LDL levels to stabilize over time while on pharmacotherapy as well as factors affecting this propensity. Results: 76 patients who contributed 864 total visits met inclusion criteria. 56 of 76 patients developed a stable LDL with median time to stability of 28 months on pharmacotherapy. Younger age of first visit was associated with development of LDL stability (9.8 years for stable LDL vs. 13.3 years for nonstable LDL; p= 0.004). Titration to higher statin doses and/or higher potency statins was also associated with higher propensity for LDL stabilization. There was no significant difference between patients who were taking a statin, ezetimibe, or both in terms of their propensity to stabilize even when stratifying for presence of probable familial hypercholesterolemia (p=0.579). 36 of 76 patients were able to reach an LDL of 130 mg/dL or less, with only 11 of 38 patients with probable familial hypercholesterolemia (>190 mg/dL baseline LDL) reaching this goal. Conclusion: A majority of children in a university pediatric cholesterol clinic were able to reach a stable LDL level on pharmacotherapy after a median 28 month interval. On the other hand, the majority of children had difficulty reaching the current recommended goal LDL of 130 mg/dL or less, even after aggressive titration of medication. This was specifically true for those with probable familial hypercholesterolemia. Further research is needed to assess the utility of goal-directed therapy in children with regards to cardiovascular outcomes." @default.
• W2898494504 created "2018-11-02" @default.
• W2898494504 creator A5023919563 @default.
• W2898494504 creator A5048950913 @default.
• W2898494504 creator A5061499497 @default.
• W2898494504 creator A5072266380 @default.
• W2898494504 date "2016-03-01" @default.
• W2898494504 modified "2023-10-16" @default.
• W2898494504 title "Abstract P030: Long-term Pharmacotherapy for Elevated Low Density Lipoprotein Levels in Children: A Retrospective Analysis" @default.
• W2898494504 doi "https://doi.org/10.1161/circ.133.suppl_1.p030" @default.
• W2898494504 hasPublicationYear "2016" @default.
• W2898494504 type Work @default.
• W2898494504 sameAs 2898494504 @default.
• W2898494504 citedByCount "0" @default.
• W2898494504 crossrefType "journal-article" @default.
• W2898494504 hasAuthorship W2898494504A5023919563 @default.
• W2898494504 hasAuthorship W2898494504A5048950913 @default.
• W2898494504 hasAuthorship W2898494504A5061499497 @default.
• W2898494504 hasAuthorship W2898494504A5072266380 @default.
• W2898494504 hasConcept C126322002 @default.
• W2898494504 hasConcept C167135981 @default.
• W2898494504 hasConcept C17923572 @default.
• W2898494504 hasConcept C207103383 @default.
• W2898494504 hasConcept C2776839432 @default.
• W2898494504 hasConcept C2778657065 @default.
• W2898494504 hasConcept C44249647 @default.
• W2898494504 hasConcept C500440147 @default.
• W2898494504 hasConcept C71924100 @default.
• W2898494504 hasConceptScore W2898494504C126322002 @default.
• W2898494504 hasConceptScore W2898494504C167135981 @default.
• W2898494504 hasConceptScore W2898494504C17923572 @default.
• W2898494504 hasConceptScore W2898494504C207103383 @default.
• W2898494504 hasConceptScore W2898494504C2776839432 @default.
• W2898494504 hasConceptScore W2898494504C2778657065 @default.
• W2898494504 hasConceptScore W2898494504C44249647 @default.
• W2898494504 hasConceptScore W2898494504C500440147 @default.
• W2898494504 hasConceptScore W2898494504C71924100 @default.
• W2898494504 hasIssue "suppl_1" @default.
• W2898494504 hasLocation W28984945041 @default.
• W2898494504 hasOpenAccess W2898494504 @default.
• W2898494504 hasPrimaryLocation W28984945041 @default.
• W2898494504 hasRelatedWork W2035157316 @default.
• W2898494504 hasRelatedWork W2147213389 @default.
• W2898494504 hasRelatedWork W2889022633 @default.
• W2898494504 hasRelatedWork W3114756237 @default.
• W2898494504 hasRelatedWork W3201140666 @default.
• W2898494504 hasRelatedWork W4213445964 @default.
• W2898494504 hasRelatedWork W4247813013 @default.
• W2898494504 hasRelatedWork W4284894593 @default.
• W2898494504 hasRelatedWork W4310563604 @default.
• W2898494504 hasRelatedWork W4321456174 @default.
• W2898494504 hasVolume "133" @default.
• W2898494504 isParatext "false" @default.
• W2898494504 isRetracted "false" @default.
• W2898494504 magId "2898494504" @default.
• W2898494504 workType "article" @default.